The company's flagship drug is finally getting enough traction to drive major margin improvements.
News & Analysis: Incyte
INCY earnings call for the period ending July 30, 2019.
The biotech beat Wall Street revenue and earnings estimates in Q2. And it could have more good news on the way.
Investors braced for bad earnings news from the biotech specialist, but Incyte surpassed those expectations late in the month.
INCY earnings call for the period ending March 31, 2019.
A fast-growing pharma and a leader in solar-power hardware have soared in 2019, but they're still buys for investors with a long-term mind-set.
INCY earnings call for the period ending December 31, 2018.
The biotech attracted more optimism from Wall Street ahead of its upcoming fourth-quarter report.
Biotech was a popular sector today. Find out why.
A number of companies suffered setbacks this year.